Regardless, the role of CXCR4 appears to have a very important role in the progression and spread of PC, thus a better understanding of expression’s influence on TACs could help direct clinical decisions and the usefulness of immunotherapy in newly diagnosed PC. This evidence concerns the gene CXCR4 and pachyonychia congenita.